RxDoctor Payments Data

Nader Zaki, MD

Hospitalist · York, PANPI 1548679368

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (55.6%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Among hospitalist clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$4,131in general payments, 2019–2025

Across 8 payments — averaging $516.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$2K
  • Modernatx, Inc.$2K
$1,118,654in research payments, 2019–2025

Across 13 payments — averaging $86,050 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$1.1M

What the payments were for

  • Consulting fees$2,29556%
  • Travel & lodging$1,30732%
  • Food & beverage$52913%

General payments by program year

22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novo Nordisk2$2,413
Modernatx, Inc.6$1,718

How this compares

$4,131 in reported general payments places this provider in the 95th percentile of 1,287 hospitalist providers in Pennsylvania.

See all hospitalist providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$108,836
Medicare patients
487
Services billed
927

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Atorvastatin Calcium14$71

Paid to pharmacies, not to this prescriber.

Other hospitalist in York

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →